Flow Cytometry Market

Global Flow Cytometry Market Size (2022 to 2027)

The global flow cytometry market size is forecasted to grow to USD 4718 Million in 2022 and reach USD 7773 Million by 2027. This market is growing at a CAGR of 10.5% during the forecast period.

Flow cytometry is a laser-based biophysical methodical technology that procedures and examines several physical features of particles postponed in a fluid as they pass through a laser beam. Flow cytometry has several advantages over traditional analytical methods, such as ELISA, including its ability to provide accurate and precise results. In addition, it is less time-consuming at approximately the same price. As a result, flow cytometry technology is used in several areas of academic research and diagnosis of HIV, hematologic malignancies, and cancer.

COVID-19 Impact on the global flow cytometry market:

The continuous COVID-19 pandemic and the global reaction have caused industries to seriously re-think their strategies and the way to operate. Biopharmaceutical creators are at the forefront of human responsibility toward the coronavirus pandemic. During the initial phases of Covid-19, the market had a minor downfall due to the stringent COVID-19 guidelines and social distancing. But later, significant progress has been made in COVID-19 diagnostics and therapeutics. In addition, biopharmaceutical companies worldwide are making efforts to develop a vaccine for the COVID-19.

The researchers have conducted many R&Ds to study the novel virus and the disease it causes. An increasing number of clinical trials for possible drug treatment.  Several research institutes and biopharmaceutical companies are doing extensive research activities to develop new Vaccines and therapies, and demand for flow cytometry increased. Moreover, flow cytometry techniques in COVID-19 research activities and clinical trials have provided opportunities for a wide range of market players.  The outbreak of COVID-19 led to the high growth of the flow cytometry market. The market is expected to register healthy growth during the forecast period.

MARKET DRIVERS:

Y-O-Y rise in the occurrence rate of chronic and infectious diseases such as cancer and HIV are majorly driving the global flow cytometry market growth.

Technological advancements, growing acquisition in cytometry techniques, increasing market perforation in existing countries, and growth in stem cell research and acquisition of recombination of DNA technologies for antibody protection are further likely to augment the growth rate of flow cytometry market.

Flow cytometry is an impedance or laser technology used in biomarker detection, cell counting, and protein engineering. It allows a detailed study of cellular structures using the software. The growing number of patients with cancer and HIV and the increasing use of flow cytometry in hospitals and diagnostic centers have created an imminent need for flow cytometry for effective diagnosis and surveillance of the disease. The fluorescence stimulated cell sorting or FACS used in flow cytometry has ensured a healthy future market.

MARKET RESTRAINTS:

The restraining factors that challenge the growth of the flow cytometry market are the availability of alternate and cheaper techniques, high costs associated with flow cytometry reagents and instruments, budget restrictions for research purposes, and expensive installation and maintenance costs.

High costs associated and the scarcity of labor and skilled technicians in the lab and clinics also hamper the flow cytometry market growth. Additionally, the lack of awareness among the end-users and less accessibility of technical expertise is further restraining the market growth during the analysis period.

REPORT COVERAGE:

This market research report on the global flow cytometry market has been segmented and sub-segmented based on technology, product, application, end-user, and region.

Flow Cytometry Market - By Technology:

• Cell-based
• Bead-based

Based on technology, the bead-based technology segment is dominating the market. Moreover, it is to increase during the forecast period due to market boosting like high speed and stability, high reproducibility, and ability to detect multiple analytes.

The bead-based segment is considered to have fast growth in the flow cytometry market over the analysis period. The segment growth owes to procedural advantages over the cell-based techniques.

Flow Cytometry Market - By Product:

• Reagents & Consumables
• Flow Cytometry Instruments

Based on the product, the reagents & consumables segment accounts for the most significant global market share in 2020. The segment growth owes extensive usage of diagnostic applications, research on cell biology and immunology, commercialization, and development of reagents and assays with better quality are expected to fuel the flow cytometry market growth.

The instruments segment is predicted to have the quickest growth in the market over the forecast period due to the launch of novel technologies, correct results, and user-friendliness.

Flow Cytometry Market - By Application:

• Research
• Clinical
• Industrial

The research segment is expected to account for the largest revenue share based on the application. The segment's growth is driven by the research and development activities related to cancer and other infectious diseases, and this segment is mainly used for the pharmaceutical research segment. In addition, various applications used across different industries fuel this application.

Flow Cytometry Market - By End-users:

• Commercial Organizations
• Research Institutes
• Clinical Testing Labs

Based on the end-user, the commercial organization's segment is considered to have the largest share of the flow cytometry market due to various applications such as food microbiology, blood banks, and plant cell culture.

The clinical testing labs segment is considered to have fast growth in flow cytometry over the forecast period, and the increase is due to an increasing number of chronic diseases. In addition, a rise in organ transplantation practices helps market growth over the forecast period.

Flow Cytometry Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Regionally, the North American flow cytometry market accounted for the largest share in the global market in 2021, followed by Europe. Factors driving the flow cytometry market in North America are increasing the application of flow cytometry techniques in cancer research, increasing adoption of low-cost and compact flow cytometers in clinical diagnostics and research laboratories, and the rising quality of infrastructure for laboratory and clinical research. The U.S. is estimated to account for the leading share in the North American market due to many clinical labs for research and significant pharmaceuticals and a high occurrence of cancer rates and other chronic conditions. The Canadian market is expected to have the quickest growth rate, followed by the U.S. in the North American flow cytometry market.

The Europe flow cytometry market is expected to perform well during the forecast period and is the second leading region, followed by North America in 2021. Factors like stem cell research, the existence of new and advanced technologies in cytometry, and the surge in the application during clinical research are strongly surging the market demand in Europe. As a result, the UK is expected to lead the European flow cytometry market during the forecast period.

The Flow Cytometry market in the Asia-Pacific region to growing at the highest CAGR, which is significant due to the increasing development and production of new biologics, vaccines, and drugs, expanding medical treatment for infectious and chronic diseases, the rising median age of the population, and increasing focus on attracting international and domestic players in the market.

The Flow Cytometry market in the Latin America region is expected to showcase a steady growth rate during the forecast period. The market growth in this region is attributed to factors such as the growing rise of HIV and cancer cases. The increased use of flow cytometry for drug discovery is expected to fuel the market of this region. Mexico is the leading country in the region due to the high occurrence of cancer growth.

The MEA flow cytometry market is expected to grow at a CAGR of 10.3% during the forecast period.

KEY MARKET PARTICIPANTS:

Noteworthy companies operating in the global flow cytometry market profiled in this report are Becton, Dickinson, and Company., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Agilent Technologies, Inc. and Affymetix Inc.

RECENT MARKET DEVELOPMENTS:

• In January 2020, Miltenyi Biotech introduced the world’s first operator with its new MACS GMP Tyto cartridge, which creates fluorescence-based, GMP-cell sorting compliant opportunities. It is used first in human trials, particularly in people with Parkinson’s disease.
• In March 2020, Sony introduced its new fluorescent dyes, KIRAVIA Dyes, used as reagents for many life science applications. These are used for tissue and cells in this field, like immunology and regenerative medicine. These KIRAVIA Dyes are organic polymers with fluorescent dyes loaded on a novel organic polymer developed by Sony.
• In June 2019, Beckman Coulter Life Sciences announced that it had acquired Cytobank. This Cytobank offers a software-based platform for multi-parametric single-cell data analysis. This technology couples with Beckman’s CytoFLEX LX-21-color flow to meet clinical researchers' high complex workflow and requirements.
• In January 2019, Luminex Corporation announced the acquisition of Millipore Sigma’s flow cytometry. This acquisition allows for increasing the flow-based detection systems and widening interactions based on microcapillary technologies. 
• In 2018, Becton Company launched a new product called BD FACSymphony S6 high parameter cell sorter.
• IN 2018, ACEA biosciences and Agilent technologies entered into a partnership to expand their product portfolio and increase revenues. 
• In September 2017, Beckman Coulter, Inc. (United States) released its first CytoFLEX LX flow cytometry for cancer researchers, with a visible spectrum in a standard configuration. This launch allowed us to develop its activity in flow cytometry. The North America Flow Cytometry Market grows due to technological progress and high adoption in various research and diagnostic applications. In addition, the increasing incidence rates of diseases such as cancer and HIV stimulate the adoption of flow cytometric technology in diagnostic applications.